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The text of the paragraph entitled “An ounce of prevention” should appear as follows. The journal regrets the error.
Cellulitis of the lower extremities is associated with signiﬁcant morbidity and health care costs. Importantly, a considerable
number of patients (estimates of 16–30%) who had a ﬁrst episode of erysipelas or uncomplicated cellulitis experience infection
recurrence. In an attempt to determine whether prophylactic antibiotic use is effective in preventing recurrent cellulitis, Oh and
colleagues performed a systematic review and meta-analysis of studies predating 2012. Five studies comprising 535 participants
were culled from databases. Results from two high-quality (PATCH) studies and three lower-quality studies indicated that
prophylactic antibiotics were beneﬁcial for preventing cellulitis (RR of 0.46, 95% CI 0.26–0.79). Although the small number of
included studies was heterogeneous, these ﬁndings support antibiotic prophylaxis against recurrent cellulitis because these
antibiotics were generally well tolerated. (J Infect 69:26–34, 2014) Selected by H. Williams.
Cell Surface CD74–MIF Interactions Drive Melanoma Survival in Response to Interferon-γ
Keiji Tanese, Yuuri Hashimoto, Zuzana Berkova, Yuling Wang, Felipe Samaniego, Jeffrey E. Lee,
Suhendan Ekmekcioglu and Elizabeth A. Grimm
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Correction to: Journal of Investigative Dermatology (2015). doi:10.1038/jid.2015.204; published online 18 June 2015.
An incomplete grant number was provided for this publication. This work was supported by the UT MD Anderson Cancer
Center SPORE in Melanoma (P50 CA093459). The authors regret the error.
Expanding the Psoriasis Disease Proﬁle: Interrogation of the Skin and Serum of Patients with Moderate-to-Severe Psoriasis
Mayte Suárez-Farin~as, Katherine Li, Judilyn Fuentes-Duculan, Karen Hayden, Carrie Brodmerkel and
James G. Krueger
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It was brought to the authors’ attention that the description of a sensitive assay to measure serum levels of IL17 in blood was not
clearly explained in the text. This sensitive assay is run only for this marker, and in the text the authors fail to state this. These
updates pertain to three sections of the text, as shown below (updates in bold). The authors regret the error.
RESULTS
The transcriptome of “moderate-to-severe” psoriasis plaques contains 4,175 differentially expressed transcripts
Using gene array, we did not detect increased expression of many T-cell-produced cytokines, e.g., IFN-γ, IL-17, or IL-22, which
consistently have been increased in psoriasis plaques, when measured by real-time reverse transcriptase PCR (RT-PCR) methods
(Suárez Fariñas et al., 2010). However by using a more sensitive technique, single molecule counting, we were able to
quantify IL-17, at levels seven times higher in psoriatic patients than in normal controls, P-valueo0.001 (Supplementary
Figure S2 online). Hence, we also measured a set of disease-related cytokine mRNAs by RT-PCR in lesional and non-lesional
tissues from this group of patients (Supplementary Table S3 online). As expected, we detected much greater expression of
mRNAs encoding IL-23 (p40 and p19 subunits), IFN-γ, IL-17, and IL-22 in lesional versus non-lesional biopsies, with expression
in psoriasis lesions ranging from 3.6-fold to 120-fold (P-values ranging from 10− 11 to 10− 29) when measured by RT-PCR, but
generallyo2-fold on gene arrays. Hence, despite a large dynamic range to measure gene expression (16 logs), microarrays are
unreliable for detecting quantitative differences in expression of these primary cytokine mRNAs generally found in low (~2 log
values) levels (Suárez Fariñas et al., 2010).
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